tradingkey.logo
tradingkey.logo
Search

GeneDx Holdings Corp

WGS
Add to Watchlist
71.710USD
+3.060+4.46%
Close 07/01, 16:00ETQuotes delayed by 15 min
2.13BMarket Cap
LossP/E TTM

More Details of GeneDx Holdings Corp Company

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corp Info

Ticker SymbolWGS
Company nameGeneDx Holdings Corp
IPO dateSep 04, 2020
CEOStueland (Katherine A)
Number of employees1000
Security typeOrdinary Share
Fiscal year-endSep 04
Address333 Ludlow Street
CitySTAMFORD
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code06902
Phone18887291206
Websitehttps://sema4.com/
Ticker SymbolWGS
IPO dateSep 04, 2020
CEOStueland (Katherine A)

Company Executives of GeneDx Holdings Corp

Name
Name/Position
Position
Shareholding
Change
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

FAQs

Who are the top five shareholders of GeneDx Holdings Corp?

The top five shareholders of GeneDx Holdings Corp are: Mr. Joshua Ruch

What is the biggest source of revenue for GeneDx Holdings Corp?

In 2026Q4, the Patients with third party insurance business generated the highest revenue for GeneDx Holdings Corp, amounting to 345.24M and accounting for 80.75% of total revenue.